Advanced in Pseudobulbar Affect

Dr. Mazen Dimachkie

Neurology
Office
3599 Rainbow Blvd # Stp, 
Kansas City, KS 
Offers Telehealth
Advanced in Pseudobulbar Affect
Office
3599 Rainbow Blvd # Stp, 
Kansas City, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Mazen Dimachkie, MD is a Clinical Neurophysiologist in Kansas City, KS and has over 34 years of experience in the medical field. He graduated from American University of Beirut / Faculty of Medicine in 1988. He is affiliated with medical facilities LMH Health and University Of Kansas Hospital.

Dr. Dimachkie is rated as an Advanced provider by MediFind in the treatment of Pseudobulbar Affect. His top areas of expertise are Myositis, Inclusion Body Myositis, Myasthenia Gravis, Thymectomy, and Tissue Biopsy.

His clinical research consists of co-authoring 198 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Pseudobulbar Affect.

Residency
University of Texas Health Science Center
Specialties
Neurology
Licenses
Psychiatry & Neurology in KS
Board Certifications
American Board Of Psychiatry And Neurology Neurology
American Board Of Psychiatry And Neurology Clinical Neurophysiology
American Board Of Psychiatry And Neurology Neuromuscular Medicine
Hospital Affiliations
LMH Health
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Office
3599 Rainbow Blvd # Stp, Kansas City, KS 66103
Call: 913-574-0834
Other Locations
University of Kansas Hospital Transplant Center
3901 Rainbow Blvd, Kansas City,, KS 66160
Call: 913-588-5000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
Enrollment Status: Completed
Publish Date: December 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Other, Biological
Study Phase: Phase 3
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis
A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Drug
Study Drug: MN-166
Study Phase: Phase 2/Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects With GNE Myopathy
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects With GNE Myopathy
Enrollment Status: Active_not_recruiting
Publish Date: June 13, 2025
Intervention Type: Other, Drug
Study Drug: N-Acetylmannosamine
Study Phase: Phase 2
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
Influence of NT5c1A Antibodies on Disease Progression, Clinical Phenotype and Blood and Muscle Biomarkers in Sporadic Inclusion Body Myositis - A Prospective Evaluation (INSPIRE-IBM Study)
Influence of NT5c1A Antibodies on Disease Progression, Clinical Phenotype and Blood and Muscle Biomarkers in Sporadic Inclusion Body Myositis - A Prospective Evaluation (INSPIRE-IBM Study)
Enrollment Status: Active_not_recruiting
Publish Date: April 09, 2024
Phase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM)
Phase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM)
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Other, Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Enrollment Status: Completed
Publish Date: October 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of IMO-8400 in Patients With Dermatomyositis
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of IMO-8400 in Patients With Dermatomyositis
Enrollment Status: Completed
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 11 Less Clinical Trials

198 Total Publications

Acquired and Genetic Amyloid Neuropathies.
Acquired and Genetic Amyloid Neuropathies.
Journal: Neurologic clinics
Published: October 29, 2025
View All 198 Publications
Similar Doctors
Richard Barohn
Advanced in Pseudobulbar Affect
Dr. Richard Barohn
Neurology
Advanced in Pseudobulbar Affect
Dr. Richard Barohn
Neurology

Office

3599 Rainbow Blvd, 
Kansas City, KS 
 (0.4 miles away)
913-588-6985
Languages Spoken:
English
See accepted insurances

Richard Barohn is a Neurologist in Kansas City, Kansas. Dr. Barohn is rated as an Elite provider by MediFind in the treatment of Pseudobulbar Affect. His top areas of expertise are Inclusion Body Myositis, Myositis, Myasthenia Gravis, Thymectomy, and Tissue Biopsy.

Advanced in Pseudobulbar Affect
Dr. David L. Ewing
Neurology
Advanced in Pseudobulbar Affect
Dr. David L. Ewing
Neurology

Heartland Regional Medical Center

105 Far W Dr, 
St Joseph, MO 
 (50.0 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Ewing is a Neurologist in St Joseph, Missouri. Dr. Ewing is rated as a Distinguished provider by MediFind in the treatment of Pseudobulbar Affect. His top areas of expertise are Memory Loss, Torticollis, Alzheimer's Disease, and Restless Legs Syndrome. Dr. Ewing is currently accepting new patients.

Experienced in Pseudobulbar Affect
Dr. Jeffrey M. Statland
Neurology
Experienced in Pseudobulbar Affect
Dr. Jeffrey M. Statland
Neurology

Kansas University Physicians Inc

3901 Rainbow Blvd, 
Kansas City, KS 
 (0.2 miles away)
913-588-7013
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Statland is a Neurologist in Kansas City, Kansas. Dr. Statland is rated as an Elite provider by MediFind in the treatment of Pseudobulbar Affect. His top areas of expertise are Facioscapulohumeral Muscular Dystrophy (FSHD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Paramyotonia Congenita, Primary Lateral Sclerosis, and Gastrostomy. Dr. Statland is currently accepting new patients.

VIEW MORE PSEUDOBULBAR AFFECT DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dimachkie's expertise for a condition
ConditionClose
  • Elite
  • Chronic Inflammatory Demyelinating Polyneuropathy
    Dr. Dimachkie is
    Elite
    . Learn about Chronic Inflammatory Demyelinating Polyneuropathy.
    See more Chronic Inflammatory Demyelinating Polyneuropathy experts
  • Dermatomyositis
    Dr. Dimachkie is
    Elite
    . Learn about Dermatomyositis.
    See more Dermatomyositis experts
  • Inclusion Body Myositis
    Dr. Dimachkie is
    Elite
    . Learn about Inclusion Body Myositis.
    See more Inclusion Body Myositis experts
  • Myasthenia Gravis
    Dr. Dimachkie is
    Elite
    . Learn about Myasthenia Gravis.
    See more Myasthenia Gravis experts
  • Myositis
    Dr. Dimachkie is
    Elite
    . Learn about Myositis.
    See more Myositis experts
  • Polymyositis
    Dr. Dimachkie is
    Elite
    . Learn about Polymyositis.
    See more Polymyositis experts
View All 7 Elite Conditions
  • Distinguished
  • Amyotonia Congenita
    Dr. Dimachkie is
    Distinguished
    . Learn about Amyotonia Congenita.
    See more Amyotonia Congenita experts
  • Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
    Dr. Dimachkie is
    Distinguished
    . Learn about Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).
    See more Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) experts
  • Chronic Polyradiculoneuritis
    Dr. Dimachkie is
    Distinguished
    . Learn about Chronic Polyradiculoneuritis.
    See more Chronic Polyradiculoneuritis experts
  • Cramp-Fasciculation Syndrome
    Dr. Dimachkie is
    Distinguished
    . Learn about Cramp-Fasciculation Syndrome.
    See more Cramp-Fasciculation Syndrome experts
  • Guillain-Barre Syndrome
    Dr. Dimachkie is
    Distinguished
    . Learn about Guillain-Barre Syndrome.
    See more Guillain-Barre Syndrome experts
  • Lambert-Eaton Syndrome
    Dr. Dimachkie is
    Distinguished
    . Learn about Lambert-Eaton Syndrome.
    See more Lambert-Eaton Syndrome experts
View All 9 Distinguished Conditions
  • Advanced
  • Andermann Syndrome
    Dr. Dimachkie is
    Advanced
    . Learn about Andermann Syndrome.
    See more Andermann Syndrome experts
  • Charcot-Marie-Tooth Disease
    Dr. Dimachkie is
    Advanced
    . Learn about Charcot-Marie-Tooth Disease.
    See more Charcot-Marie-Tooth Disease experts
  • Congenital Myasthenic Syndrome
    Dr. Dimachkie is
    Advanced
    . Learn about Congenital Myasthenic Syndrome.
    See more Congenital Myasthenic Syndrome experts
  • Danon Disease
    Dr. Dimachkie is
    Advanced
    . Learn about Danon Disease.
    See more Danon Disease experts
  • Delta-Sarcoglycanopathy
    Dr. Dimachkie is
    Advanced
    . Learn about Delta-Sarcoglycanopathy.
    See more Delta-Sarcoglycanopathy experts
  • Diabetic Neuropathy
    Dr. Dimachkie is
    Advanced
    . Learn about Diabetic Neuropathy.
    See more Diabetic Neuropathy experts
View All 23 Advanced Conditions
  • Experienced
  • Acute Flaccid Myelitis (AFM)
    Dr. Dimachkie is
    Experienced
    . Learn about Acute Flaccid Myelitis (AFM).
    See more Acute Flaccid Myelitis (AFM) experts
  • Brachial Plexopathy
    Dr. Dimachkie is
    Experienced
    . Learn about Brachial Plexopathy.
    See more Brachial Plexopathy experts
  • Chronic Demyelinizing Neuropathy with IgM Monoclonal
    Dr. Dimachkie is
    Experienced
    . Learn about Chronic Demyelinizing Neuropathy with IgM Monoclonal.
    See more Chronic Demyelinizing Neuropathy with IgM Monoclonal experts
  • Congenital Insensitivity to Pain with Anhidrosis
    Dr. Dimachkie is
    Experienced
    . Learn about Congenital Insensitivity to Pain with Anhidrosis.
    See more Congenital Insensitivity to Pain with Anhidrosis experts
  • Cytoplasmic Body Myopathy
    Dr. Dimachkie is
    Experienced
    . Learn about Cytoplasmic Body Myopathy.
    See more Cytoplasmic Body Myopathy experts
  • Dysferlinopathy
    Dr. Dimachkie is
    Experienced
    . Learn about Dysferlinopathy.
    See more Dysferlinopathy experts
View All 49 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.